Whole Body Vibration in Chronic Obstructive Pulmonary Disease

Not Applicable

Completed

• Conditions: COPD
• Interventions: Device: A vertical vibration platform Fitybe

• Registration Number: NCT01850173
• Lead Sponsor: Hospital de Mataró

Brief Summary

The investigators designed the current study with the main objective of determining whether Whole Body Vibration Training (WBVT) alone improves muscular force and/or modifies the functional capacity parameters in severe Chronic Obstructive Pulmonary Disease (COPD) patients referred to a rehabilitation programme.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-02
• Primary Completion: 2011-12
• Study Completion: 2011-12
• Status Verified: 2013-05
• Study First Submitted: 2013-05-02
• Study First Submitted QC: 2013-05-06
• Last Update Submitted: 2013-05-06
• Study First Posted: 2013-05-09
• Last Update Posted: 2013-05-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

• severe COPD defined as a post-bronchodilator forced expiratory volume at one second (FEV1)/ forced vital capacity (FVC) < 0.7 and FEV1 < 50% predicted,
• stable disease defined as no exacerbation,
• hospital admission or change in treatment in the previous 3 months.

Exclusion Criteria

• other significant respiratory disease (bronchiectasis,
• lung fibrosis, asthma, etc),
• active smoking,
• severe cardiovascular,
• neurological, and/or metabolic pathology that could interfere with the results,
• total hip, knee or ankle arthroplasty,
• previous vitreous haemorrhage,
• severe alcoholism (> 80 g/day) and
• severe malnutrition (BMI < 19 Kg/m2) to reduce the risk of falling and dropouts.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
static work with a vertical vibration platform	A vertical vibration platform Fitybe	The training was designed to perform static work of the lower limbs. Patients worked in a squatting position, with 30º of hip flexion and 55º of knee flexion, holding onto the bars of the WBV platform.

Primary Outcome Measures

Name	Time	Method
isokinetic knee flexor and extensor testing muscular force	basal, 3 months follow up	the change between basal - and 3 months follow up.
distance performed in the six minutes walking test (6MWT)	Basal, 3 months follow up	the change between basal - and 3 months follow up.

Secondary Outcome Measures

Name	Time	Method
respiratory muscular strength was assessed with maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)	Basal, 3 month follow up	the change between basal - and 3 months follow up.

Trial Locations

Locations (1)

Eulogio Pleguezuelos; 🇪🇸 Mataró, Barcelona, Spain